Financial Transparency

Daiichi Sankyo is committed to bringing pharmaceutical innovation from bench to bedside. Innovation is paramount in all that we do, from pursuing new medicines and new methods of drug discovery and delivery, to achieving excellence throughout our organization.

Disclosure of Payments to Healthcare Professionals, Healthcare Organisations and Patient Organisations

A fruitful working relationship between the pharmaceutical industry and healthcare professionals has helped develop many life-saving medicines and has long been a positive driver for advancements in patient care and the progression of research.

EFPIA Disclosure Initiative

We fully support transparency and are prepared to disclose proper documentation of all our transfers of value to healthcare professionals (HCP), healthcare organisations (HCO) and patient organisations under the EFPIA Disclosure Code and according country specific applicable laws and regulations.

Disclosure Reports

European Affiliates:

European Headquarter:

Self-Certificate Disclosure Code

back to top

User login

Enter your username and password here in order to log in on the website